ES2061453T3 - Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina. - Google Patents

Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.

Info

Publication number
ES2061453T3
ES2061453T3 ES87111467T ES87111467T ES2061453T3 ES 2061453 T3 ES2061453 T3 ES 2061453T3 ES 87111467 T ES87111467 T ES 87111467T ES 87111467 T ES87111467 T ES 87111467T ES 2061453 T3 ES2061453 T3 ES 2061453T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
pseudohipericina
compositions containing
hypericin
antiviral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87111467T
Other languages
English (en)
Inventor
David Lavie
Michel Revel
Dalia Rotman
Velde Vincent Vande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of ES2061453T3 publication Critical patent/ES2061453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE EL USO DE LA HIPERICINA O DE LA SEUDOHIPERICINA COMO SUSTANCIA TERAPEUTICAS ACTIVAS PARA EL TRATAMIENTO Y ALIVIO DE LOS SINTOMAS DE DIVERSAS ENFERMEDADES PRODUCIDAS POR VIRUS, TALES COMO LA ESTOMATITIS VESICULAR, LA GRIPE, EL HERPOS SIMPLEX, EL HSV-1 Y EL HSV-2. EL MODO DE ACTIVIDAD PARECE SER LA INHIBICION DE LA SINTESIS DEL RNA Y LA INTERFERENCIA CON LA REPLICACION DEL VIRUS. LAS COMPOSICIONES FARMACEUTICAS PUEDEN APLICARSE MEDIANTE UNA DIVERSIDAD DE VIAS. LAS APLICACIONES TOPICAS HAN DEMOSTRADO SER EFICACES CONTRA UNA VARIEDAD DE ENFERMEDADES VIRICAS.
ES87111467T 1986-08-08 1987-08-07 Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina. Expired - Lifetime ES2061453T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79661A IL79661A (en) 1986-08-08 1986-08-08 Antiviral composition containing hypericin or pseudohypericin

Publications (1)

Publication Number Publication Date
ES2061453T3 true ES2061453T3 (es) 1994-12-16

Family

ID=11057015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87111467T Expired - Lifetime ES2061453T3 (es) 1986-08-08 1987-08-07 Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.

Country Status (6)

Country Link
US (2) US5047435A (es)
EP (1) EP0256452B1 (es)
AT (1) ATE96663T1 (es)
DE (1) DE3788016T2 (es)
ES (1) ES2061453T3 (es)
IL (1) IL79661A (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
EP0332679B1 (en) * 1987-08-10 1993-06-16 New York University Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
AU3423989A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
AU3294289A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
IL93682A (en) * 1989-03-16 1996-06-18 Yeda Res & Dev Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5316768A (en) 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
WO1993014197A1 (en) * 1992-01-16 1993-07-22 New York University Hypericin treatment of vaccine agents for improved immunogenicity
AU5959994A (en) * 1992-12-23 1994-07-19 Iowa State University Research Foundation Inc. Molecular flashlight
DE9316320U1 (de) * 1993-10-20 1994-01-20 Beni Med Natuerliche Heilmitte Kosmetische Zubereitung in Form von Lippenstiften mit antiviraler Wirkung
DE19547317A1 (de) * 1995-12-18 1998-12-24 Dreluso Pharm Dr Elten & Sohn Antivirales Medikament
GR1002799B (el) * 1996-11-19 1997-11-04 Αντιικη δραση του φυτου hypericum perforatum l. κατα του ανθρωπινου κυτταρομεγαλοιου.
IL119833A (en) * 1996-12-15 2001-01-11 Lavie David Hypericum perforatum extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
US6428819B1 (en) 1996-12-15 2002-08-06 David Lavie Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
DE19700788A1 (de) * 1997-01-11 1998-07-16 Michael O Ruepp Johanniskraut-Trockenextrakte
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
JP2002509111A (ja) * 1998-01-13 2002-03-26 レクソール サンダウン インコーポレイテッド オトギリソウ及びメチル供与体組成物、並びにその使用
US6238671B1 (en) 1998-04-22 2001-05-29 Bionorica Arzneimittel Gmbh Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use
US6159986A (en) * 1999-11-02 2000-12-12 Altman; David A. Compounds and therapy for resisting memory loss in humans
DE10131641A1 (de) 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
US7037534B2 (en) * 2001-10-24 2006-05-02 Aphios Corporation Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
WO2004047821A1 (en) * 2002-11-25 2004-06-10 New York University Methods for preventing phototoxic damage during photodynamic therapy
US20100048728A1 (en) * 2006-08-03 2010-02-25 Hy Biopharma Inc. Polycyclic dianthraquinones as inhibitors of inflammatory cytokines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US4209532A (en) * 1977-03-28 1980-06-24 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclohexane dione compounds and alkali metal and ammonium salts thereof
US4338122A (en) * 1979-09-26 1982-07-06 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione compounds and alkali metal and ammonium salts thereof
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
JPS59190921A (ja) * 1983-04-11 1984-10-29 Junko Nozaki 抗ウイルス活性物質

Also Published As

Publication number Publication date
US5049589A (en) 1991-09-17
IL79661A (en) 1991-01-31
DE3788016D1 (de) 1993-12-09
IL79661A0 (en) 1987-08-31
EP0256452A3 (en) 1990-01-17
ATE96663T1 (de) 1993-11-15
US5047435A (en) 1991-09-10
EP0256452B1 (en) 1993-11-03
EP0256452A2 (en) 1988-02-24
DE3788016T2 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
BR9810745A (pt) Derivados de benzimidazol
ES2147294T3 (es) Compuestos terapeuticos.
FI20001231A (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
CO4940451A1 (es) Derivados de acido barbiturico con actividad antimetastica y antitumoral
SE8703066L (sv) Antiseptisk komposition innehallande etylalkohol och monolaurin
ATE36331T1 (de) Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung.
AR012946A1 (es) Forma cristalina a de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
NO983090L (no) Terapeutiske forbindelser
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
ES2191662T3 (es) Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales.
MC1930A1 (fr) Produit antiviral
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ES455721A1 (es) Procedimiento para la preparacion de una nueva sal de pipe- raziniluracilo.
ES2081782T1 (es) Extractos procedentes de piliostigma thonningil, usos de estos y formulaciones que los contienen.
BR0011049A (pt) Fenilciclohexanocarboxamidas substituìdas e seu uso como inibidores de absorção de adenosina
MX9303985A (es) Nucleosidos terapeuticos.
DK0576506T3 (da) Anvendelse af benzimidazol-anthelmintikum ved behandling af mikrosporidial-infektioner
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
ES2140329B1 (es) Utilizacion de acido maslinico como inhibidor de proteasas para el tratamiento de la enfermedad causada por los virus de la inmunodeficiencia adquirida.
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
MX9203068A (es) Compuestos activirales oralmente activos.
RU94016333A (ru) Лекарственное средство для лечения вирусных заболеваний

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 256452

Country of ref document: ES